Safety and Efficacy of Activated Recombinant Human Factor VII in Patients Undergoing Orthotopic Liver Transplantation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
This trial is conducted in Europe, North America and Oceania. The aim of this trial is to evaluate the haemostatic efficacy of activated recombinant human factor VII in subjects undergoing orthotopic liver transplantation surgery.
Epistemonikos ID: fe245414cc1b81ea48137192ded4468e85e9d6f9
First added on: May 10, 2024